Five Trials To Look Out For At The AHA Meeting

Cardiovascular Conference Will Highlight Studies Of Inclisiran, Apabetalone, Vascepa, Farixiga And Brilinta

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.